Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

fludarabine phosphate 11Cyclophosphamide 11Whole-Body Irradiation 8Mycophenolic Acid 8Busulfan 7fludarabine 6Tacrolimus 6Peripheral Blood Stem Cell Transplantation 6Melphalan 5Rituximab 4Biopsy 4Azacitidine 4venetoclax 3thymoglobulin 3apixaban 3Methotrexate 3Cyclosporine 3Antilymphocyte Serum 3decitabine and cedazuridine drug combination 2Vorinostat 2Vancomycin 2Tretinoin 2Specimen Handling 2Sirolimus 2Lenalidomide 2Injections 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Decitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
oprelvekin × Classical hematology × 90 days × Clear all
NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
88 enrolled
Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡